The FDA has granted orphan drug designation to AC102, concluding that AudioCure’s lead compound may become of significant benefit for patients suffering with the rare and chronically debilitating disease of sudden sensorineural hearing loss (SSNHL). Comprehensive...
This website uses cookies. By clicking on the “Ok” button, you consent to our use of cookies as described in our Privacy Notice. If you continue to use this site we will assume that you agree with our Privacy Police.
